MORGAN STANLEY: Here are the 10 healthcare companies most likely to get bought this year

AP

Allergan is among the healthcare companies Morgan Stanley sees as a possible M&A target.

It's shaping up to be a big year for healthcare M&A.

In the month of January alone, there was a total of $27.5 billion worth of deals, including a $9 billion deal for a cancer drugmaker and a bidding war for a Belgian biotech.

US tax reform has freed up a lot of cash companies had overseas - cash that might be spent on more acquisitions to boost their businesses.

While it's easy to determine who might be in the mood to do some acquiring, spotting the targets can be a bit more difficult.

To help out, Morgan Stanley compiled a list of large and liquid companies it thinks will get at least one tender offer over the next 12 months. While the Morgan Stanley note contained 21 companies, we stuck to just the top 10 by market cap and trading volume.